Skip to content
Research Article Open access CC BY 4.0

Successful Management of Multi-Drug Resistant TB in Pregnancy: A Case Report

E. C. Iwuoha, E. O. Ezirim

Asian Journal of Pregnancy and Childbirth · pp. 134–137 · Published 24 Aug 2021

10.9734/ajpcb/2021/v4i144

Abstract

Multi-drug resistant Tuberculosis (MDRTB) affects persons of all ages including women of child bearing age. The management of Multidrug resistant TB in pregnancy is controversial. However current guidelines for programmatic management of MDRTB include commencing pregnant women on treatment after the first trimester. Possible side effects of the drugs especially teratogenicity has been the major concern on whether or not to commence pregnant mothers. We present a case of a 35 years old multi-gravida Nigerian woman who was managed for MDRTB during pregnancy. The patient was a previously drug sensitive TB patient who was treated for TB but lost to follow-up. At presentation pregnancy which was singleton was estimated at 19 weeks by Abdominal Ultra sound scan. Patient was treated with second line anti-Tb drugs and delivered at 38 weeks gestation; a healthy female baby with a birth weight of 2.5 kg. Conclusions: Pregnant MDRTB patients can have successful outcomes if commenced on treatment after first trimester.

Pregnancy multi-drug resistant TB second line drugs

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.